Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
UNIGENE LABORATORIES INC (UGNE)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Mar-31-13 | Dec-31-12 | Sep-30-12 | Jun-30-12 | Mar-31-12 | Dec-31-11 | Sep-30-11 | Jun-30-11 |
| | 10-Q | 10-K | 10-Q | 10-Q/A | 10-Q | 10-K | 10-Q | 10-Q/A |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 266.5% | 4.4% | 25.2% | 20.7% | 14.1% | 3.9% | 16.4% | 13.6% |
| Gross profit | -166.5% | 95.6% | 74.8% | 79.3% | 85.9% | 96.1% | 83.6% | 86.4% |
| Selling, general and administrative | 321.8% | 74.4% | 73.0% | 99.0% | 119.5% | 15.7% | 70.7% | 116.3% |
| Research and development | 138.6% | 209.5% | | | 71.9% | 66.6% | | |
| General and administrative | | | | | | | | |
| EBITDA | -760.3% | -222.6% | -63.4% | -88.6% | -196.2% | -43.0% | -116.2% | -153.8% |
| Depreciation | -47.2% | -83.0% | -12.2% | | -7.7% | -75.4% | -11.6% | |
| EBIT | -713.1% | -113.9% | -51.2% | -88.6% | -151.4% | 53.2% | -104.6% | -153.8% |
| Pre-tax income | 322.4% | -903.7% | -136.7% | -514.2% | -184.0% | 194.5% | -119.8% | 117.4% |
| Income taxes | 0.0% | -48.7% | 0.0% | 0.0% | -1.5% | -4.4% | 0.0% | 0.0% |
| Net income | 322.4% | -1352.7% | 0.0% | 0.0% | -182.5% | -52.4% | 0.0% | 0.0% |
|